MARK THOMAS / SCIENCE PHOTO LIBRARY MARK THOMAS / SCIENCE PHOTO LIBRARY
Sativex multiple sclerosis drug. Pharmacist holding a box containing Sativex. This cannabinoid oromucosal mouth spray was developed by GW Pharmaceuticals for multiple sclerosis patients. It is used to alleviate neuropathic pain, spasticity, overactive bladder, and other symptoms. It is also being trialled as a pain control drug for cancer patients.
Model release available. Property release not available.